Agios Pharmaceuticals' Mitapivat Approval Boosts Revenue

Markets & Money Today | 2 Min News | The Daily News Now! - Een podcast door The Daily News Now! - Dinsdagen

Probeer Podimo de eerste 60! dagen gratis

Probeer Podimo de eerste 60! dagen gratis

Luister 30 dagen gratis naar exclusieve podcasts en duizenden luisterboeken

 Sponsored
Podcast artwork

Categorieën:

Zakelijk

Agios Pharmaceuticals mitapivat, sold as Aqvesme, gains FDA approval for treating anemia in thalassemia patients, potentially unlocking $320M in peak revenue.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site